Analysis of the Factors Affecting Clinical Outcomes of Patients Undergoing Fresh Embryo Transfer Cycles with Antagonist Protocol
- VernacularTitle:拮抗剂方案新鲜胚胎移植周期患者临床结局的影响因素分析
- Author:
Xuehua FENG
1
;
Jiao JIAO
1
;
Xiaojun FENG
1
;
Yi YAO
1
Author Information
1. 山东中医药大学第二附属医院生殖医学科,山东济南 250001
- Publication Type:Journal Article
- Keywords:
Antagonist protocol;
Fresh embryo transfer cycles;
Clinical pregnancy outcome
- From:
Journal of Practical Obstetrics and Gynecology
2025;41(5):425-430
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the factors affecting clinical pregnancy outcomes in fresh embryo transfer cycles of patients undergoing ovulation induction with antagonist protocol.Methods:Data from 1001 patients un-dergoing their first antagonist protocol fresh embryo transfer cycle at Department of Reproductive Medicine,The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine,from December,2016 to June,2024 were collected.Patients were stratified into two groups based on pregnancy outcomes:clinical pregnancy(502 cases)and non-clinical pregnancy(499 cases).General characteristics,controlled ovarian stimulation pa-rameters,and laboratory data were analyzed.Independent factors affecting clinical pregnancy were identified through univariate analysis and multivariate binary Logistic regression analysis.Results:Multivariate binary Logis-tic regression analysis indicated that advanced maternal age(≥35 years)and HCG-day progesterone(P)levels were identified as inhibitory factors for clinical pregnancy(OR 0.571,95％CI 0.400-0.815,P＜0.05;OR 0.832,95％CI 0.720-0.961,P＜0.05).Endometrial thickness on HCG-day,2PN cleavage rate,and the number of trans-ferable embryos were significant positive predictors of clinical pregnancy(OR 1.095,95％CI 1.011-1.186;OR 1.036,95％CI 1.006-1.067,P＜0.05;OR 1.122,95％CI 1.039-1.211,P＜0.05).Embryo transfer strategy signifi-cantly impacted outcomes:transferring one cleavage-stage embryo or one blastocyst resulted in lower pregnancy rates compared to dual cleavage-stage embryo transfer(OR0.359,95％CI 0.195-0.658,P＜0.05;OR 0.457,95％CI 0.285-0.733,P＜0.05).Conclusions:Maternal age,HCG-day P levels,endometrial thickness on HCG-day,2PN cleavage rate,number of transferable embryos and embryo transfer strategy are independent pre-dictors of clinical pregnancy in antagonist protocol of fresh cycles.Individualized treatment protocols should con-sider these factors and maternal-infant health priorities to optimize pregnancy success.
